2003
DOI: 10.1179/096805103125001513
|View full text |Cite
|
Sign up to set email alerts
|

Macrophage migration inhibitory factor (MIF) regulates host responses to endotoxin through modulation of Toll-like receptor 4 (TLR4)

Abstract: The cytokine macrophage migration inhibitory factor (MIF) has emerged recently as an important mediator of inflammation and innate immunity. MIF is rapidly released by macrophages after stimulation with microbial products and pro-inflammatory cytokines and, in turn, stimulates the production of pro-inflammatory mediators by immune cells. Immunoneutralization of MIF or deletion of the Mif gene was shown to protect animals from lethal endotoxemia, staphylococcal toxic shock and septic shock in experimental model… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

8
32
0
2

Year Published

2005
2005
2022
2022

Publication Types

Select...
8

Relationship

1
7

Authors

Journals

citations
Cited by 54 publications
(42 citation statements)
references
References 14 publications
8
32
0
2
Order By: Relevance
“…Previous studies have recognized MIF as the first molecule to arrive at the inflammation site and the factor that likely determines the degree of cellular inflammation [21]. MIF is known to counter-regulate the immunosuppressive effects of steroids [7] and to over-regulate the expression of Toll-like receptor (TLR)-4 on antigen-presenting cells [29]. MIF has been implicated in both types of diabetes [32], and there is evidence linking MIF with DN.…”
Section: Introductionmentioning
confidence: 98%
“…Previous studies have recognized MIF as the first molecule to arrive at the inflammation site and the factor that likely determines the degree of cellular inflammation [21]. MIF is known to counter-regulate the immunosuppressive effects of steroids [7] and to over-regulate the expression of Toll-like receptor (TLR)-4 on antigen-presenting cells [29]. MIF has been implicated in both types of diabetes [32], and there is evidence linking MIF with DN.…”
Section: Introductionmentioning
confidence: 98%
“…It is a pharmacological target for treatment of septic shock and cancer with specific antibodies (Willson 2003). MIF-blocking antibodies prevented the lethal effect in animals modeling septic shock, whereas MIFknockout mice are tolerant to lethal concentrations of lipopolysaccharide (LPS) (Bozza et al 1999;Roger et al 2003).…”
Section: Introductionmentioning
confidence: 99%
“…In addition, antisense MIF suppresses TLR4 promoter activity and TNF production. Another study by Roger et al (2003) has also demonstrated that MIF regulates host responses to endotoxin through modulation of TLR4 in macrophages. MIF-deficient macrophages have revealed the down-regulation of TLR4 expression and hyporesponsiveness to stimulation with LPS or Gram-negative bacteria.…”
Section: Discussionmentioning
confidence: 93%